Denial Rate Benchmarks by Specialty: Where Does Your Practice Stand?
When a practice administrator reports a 7% denial rate, the natural question is: compared to what? A 7% denial rate in family medicine carries different implications than a 7% denial rate in interventional cardiology. The complexity of procedures, the mix of payers, the volume of prior authorizations, and the specificity of coding requirements all vary dramatically by specialty. Meaningful benchmarking requires specialty-specific context, and most practices do not have it.
The Problem With Industry Averages
The commonly cited industry-wide denial rate hovers between 5% and 10%, depending on the source. The American Academy of Family Physicians (AAFP) has referenced denial rates in the 5% to 7% range for primary care. The Advisory Board has published figures suggesting overall hospital denial rates closer to 10% to 12%. MGMA surveys consistently show variation by practice size, region, and specialty. These aggregate numbers are useful for headlines but nearly useless for operational decision-making.
The reason is straightforward: a denial in dermatology for a cosmetic procedure coded incorrectly is a fundamentally different problem than a denial in neurosurgery for a prior authorization that was not obtained in time. Aggregating them into a single percentage obscures the root causes, the financial impact per denial, and the appropriate remediation strategy. Practices need to benchmark against their peers, not against the entire healthcare industry.
Specialty-Specific Benchmarks
While no single data source provides definitive benchmarks for every specialty, a composite picture emerges from MGMA surveys, specialty society publications, and claims clearinghouse data. The following ranges represent reasonable targets based on available evidence. Your practice should track its own trend over time, using these as directional guidance rather than absolute standards.
Primary Care and Internal Medicine
Primary care practices typically see denial rates between 4% and 7%. The most common denial reasons involve eligibility issues, duplicate claims, and E/M level coding disputes. Because primary care involves high volume and relatively low reimbursement per claim, even a modest denial rate creates significant cumulative revenue loss. A practice seeing 80 patients per day with a 6% denial rate and an average claim value of $150 is losing roughly $720 per day to denials — over $180,000 annually before accounting for rework costs.
Orthopedics and Surgical Specialties
Orthopedic and surgical practices often report denial rates between 6% and 10%. The higher rates reflect the complexity of surgical coding, the prevalence of prior authorization requirements, and the frequency of bundling and unbundling disputes. A single denied surgical claim can exceed $5,000, making denial management in these specialties disproportionately high-value. Prior authorization failures and medical necessity denials are the most common — and most preventable — categories.
Cardiology
Cardiology practices operate in a denial range of 5% to 9%, with significant variation between practices focused on diagnostic testing versus interventional procedures. Diagnostic cardiology faces frequent denials related to medical necessity for stress tests, echocardiograms, and nuclear imaging. Interventional cardiology encounters prior authorization denials and coordination of benefits issues. The financial impact per denial is substantial — a denied cardiac catheterization can represent $8,000 to $15,000 in lost revenue.
Gastroenterology
GI practices typically experience denial rates between 5% and 8%. Endoscopy and colonoscopy coding is a frequent source of denials, particularly around screening versus diagnostic designations. The distinction between a screening colonoscopy that converts to a diagnostic procedure — and the associated coding and billing implications — remains one of the most common sources of patient complaints and payer disputes in the specialty.
Dermatology
Dermatology denial rates range from 4% to 7%, with the primary drivers being cosmetic versus medical necessity determinations, pathology coding, and Mohs surgery authorization. Practices with a significant cosmetic component may see higher apparent denial rates if cosmetic claims are inadvertently submitted to insurance. Excluding truly cosmetic procedures from the calculation provides a more accurate picture of the medical billing denial rate.
Behavioral Health and Psychiatry
Behavioral health practices face some of the highest denial rates in medicine, often between 8% and 12%. Contributing factors include parity compliance issues, authorization requirements for ongoing therapy, and the complexity of billing for integrated behavioral health services. The Mental Health Parity and Addiction Equity Act has improved coverage but has not eliminated the administrative burden of demonstrating medical necessity for continued treatment.
How to Use Benchmarks Effectively
Knowing that your specialty's benchmark denial rate is 6% and your practice is at 9% is only valuable if you take the next step: understanding why. Effective use of benchmarks requires three practices.
Stratify by Denial Reason
Aggregate denial rates mask the underlying causes. Break your denials into categories: eligibility and registration errors, coding and modifier issues, prior authorization failures, medical necessity disputes, timely filing, and duplicate claims. This stratification reveals whether your problem is at the front desk, in the coding department, or in the clinical documentation. A practice with a 9% denial rate driven primarily by eligibility errors needs a completely different intervention than one driven by medical necessity denials.
Measure Financial Impact, Not Just Volume
A practice might have a 5% denial rate by claim count but a 12% denial rate by dollar amount if high-value claims are disproportionately denied. Always measure denials both ways. The dollar-weighted denial rate is the more operationally relevant number because it reflects actual revenue at risk. Some practices discover that a small number of high-dollar denials account for the majority of their financial exposure.
Track Overturn Rate
The denial rate alone does not tell the full story. What matters equally is the appeal success rate — the percentage of denied claims that are overturned on appeal. Industry data from the AMA suggests that roughly 50% to 65% of appealed claims are eventually overturned, yet fewer than half of denied claims are ever appealed. This represents an enormous revenue recovery opportunity. Practices should track their overturn rate alongside their denial rate to ensure they are not leaving recoverable revenue on the table.
Building Your Own Benchmark
External benchmarks provide context, but the most useful benchmark is your own practice over time. Establish a baseline by measuring your denial rate — by count and by dollar amount — for three consecutive months. Then track monthly, comparing each period to your own baseline rather than to an industry number you cannot fully validate. This internal trending reveals whether your operational changes are working, which is ultimately more actionable than knowing where you stand relative to a national average derived from survey data with variable response rates.
The goal is not to reach a specific number. It is to understand your denial patterns deeply enough to intervene at the root cause, measure the impact of those interventions, and drive continuous improvement. Benchmarks are a starting point for that conversation, not the destination.